From highs & lows to steady progress: assessing the shifting I–O clinical landscape

Roisin McGuigan, Editor, Immuno-Oncology Insights, speaks with (pictured) Andrew Baum, Head of Global Healthcare at Citibank for insights on the shifting clinical landscape in I–O, and what’s needed to accelerate progress in the space.

Please enter your email to access content Read now